UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine

By Goetz Matthew   McKean Heidi   Reid Joel   Mandrekar Sumithra   Tan Angelina   Kuffel Mary   Safgren Stephanie   McGovern Renee   Goldberg Richard   Grothey Axel   McWilliams Robert   Erlichman Charles   Ames Matthew  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1559-1567

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of Uridine Diphosphoglucuronosyltransferase (UGT) 1A Family Members and its Role in Patient Response to Irinotecan*

By Nagar Swati   Blanchard Rebecca  

Drug Metabolism Reviews, Vol. 38, Iss. 3, 2006-06 ,pp. : 393-409

Informa Healthcare

Access to resources Recommend Favorite

ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 23-30

Bentham Science Publishers

Access to resources Recommend Favorite

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

By Font Albert   Sánchez José Miguel   Tarón Miquel   Martinez-Balibrea Eva   Sánchez José Javier   Manzano José Luis   Margelí Mireia   Richardet Martin   Barnadas Agustí   Abad Albert   Rosell Rafael  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 435-443

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations

By Mehlotra Rajeev   Bockarie Moses   Zimmerman Peter  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 1, 2007-01 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite